Dual-Energy Computed Tomography (DECT) in Acute Neck Infections: Comparison With Magnetic Resonance Imaging (MRI)
ANI-DECT
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this prospective study is to compare MRI and DECT in imaging acute neck infection. 50 patients suspected for neck infection will undergo both modalities, which will then be compared in terms of depiction of edema, conspicuity of inflammation, and characterization and number of abscesses. We hypothesize that DECT will have diagnostic performance comparable to that of MRI, and superior to that of traditional single-energy CT. This study will yield important new information about the performance of DECT, a novel and rapid method for emergency imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2022
CompletedStudy Start
First participant enrolled
March 22, 2022
CompletedFirst Posted
Study publicly available on registry
March 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMarch 31, 2022
March 1, 2022
3.9 years
March 22, 2022
March 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy
Diagnostic accuracy relative to clinical reference standard (clinical diagnosis or surgery)
1 day
Study Arms (1)
DECT and MRI
EXPERIMENTALPatients will be scanned with both DECT and MRI.
Interventions
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Suspicion of acute neck infection as deemed by the referring physician
You may not qualify if:
- History of a serious adverse reaction to intravenous iodine- or gadolinium-based contrast agent
- Severe kidney dysfunction (eGFR \< 30 mL/min/1.73m2)
- Foreign metallic objects incompatible with MRI in the body
- Inability to give informed consent, as deemed by study physician
- Inability to follow study instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Turku University Hospital
Turku, 20521, Finland
Study Officials
- PRINCIPAL INVESTIGATOR
Jussi Hirvonen, MD, PhD
Turku University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Radiologist
Study Record Dates
First Submitted
March 22, 2022
First Posted
March 31, 2022
Study Start
March 22, 2022
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
March 31, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share